Wild-type JAK2 may suppress mutant JAK2 activity in cytokine receptor activation

Sota Kitazawa

Presentation information

Oral Session

Oral Session 1-13A MPN: Basic (1)

Fri. Oct 12, 2018 9:00 AM - 10:00 AM No.13 (Osaka International Convention Center, 11F 1101-2)

Chair: Takuro Kameda (Gastroenterology hematology, Faculty of Medicine, University of Miyazaki, Japan)

【Ｅ】

[OS1-13A-3] Wild-type JAK2 may suppress mutant JAK2 activity in cytokine receptor activation

Sota Kitazawa¹, Marito Araki², Soji Morishita², Yinjie Yang¹, Misa Imai^1,3, Akimichi Ohsaka², Norio Komatsu¹ (1.Hematology., Juntendo University Graduate School., Tokyo, Japan, 2.Dept. Transfus. Med. and Stem Cell Reg., Juntendo Univ., Japan, 3.Lead. Cent. Dev. Res. Cancer Med., Juntendo Univ., Tokyo, Japan)

Abstract password authentication.
Password is written on a program and abstract book.